1. DIAN-TU treatment trial Dr Christopher Lane Clinical Research Associate, Dementia Research Centre 2. Overview • What has the DIAN –L study taught us? • DIAN –…
Slide 1 Fragile X Laboratory Testing: Background and Quality Improvement Opportunities (part 1 of 2) Elaine Lyon, Ph.D. University of Utah/ARUP Laboratories Association for…
Slide 1 Genetics and Risk of Breast Cancer What is the Evidence Slide 2 Questions What is the role of mutation testing What is the risk to mutation carriers What is the evidence…
Oregon Genetics Program: a state perspective Oregon Genetics Program: Enhancing Breast Cancer Genomic Practices Summer Lee Cox, MPH Advisory Committee on Breast Cancer in…